You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stem cell transplantation

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early Supraglottic Squamous Cell Carcinoma With Advance

Recruiting
  • Supraglottic Squamous Cell Carcinoma
  • Early Stage (T1-T2, N0-N1,M0)
  • TORS
  • Yvoir, Namur, Belgium
    CHU UCL Namur
Nov 3, 2022

T-cell Lymphoma, Relapsed and Refractory T-cell Lymphoma Trial in New York, Columbus (Ibrutinib)

Active, not recruiting
  • T-cell Lymphoma
  • Relapsed and Refractory T-cell Lymphoma
  • New York, New York
  • +1 more
Nov 8, 2022

Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

Recruiting
  • Lung Cancer
  • Olaparib+Bevacizumab to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
  • +3 more
Nov 9, 2022

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT041 autologous CAR T-cell injection
  • Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）
  • Hefei, Anhui, China
  • +9 more
Feb 13, 2022

Non-Squamous NSCLC Trial in Guangzhou (AK112 Injection, Placebo Injection)

Recruiting
  • Non-Squamous Non-small Cell Lung Cancer
  • AK112 Injection
  • Placebo Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 23, 2022

Knee Osteoarthritis Trial (INMUNOCEM, PLACEBO COMPARATOR)

Not yet recruiting
  • Knee Osteoarthritis
  • INMUNOCEM
  • PLACEBO COMPARATOR
  • (no location specified)
Jun 29, 2023

ITP Trial in Suzhou (autologous anti-BCMA chimeric antigen receptor T cells)

Recruiting
  • ITP
  • autologous anti-BCMA chimeric antigen receptor T cells
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 31, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Lung Tumors Trial (Envafolimab, Endostar)

Not yet recruiting
  • Lung Neoplasms
  • (no location specified)
Feb 8, 2022

HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)

Recruiting
  • HIV-1-infection
  • 426c.Mod.Core-C4b 30 mcg
  • +3 more
  • Birmingham, Alabama
  • +5 more
Jul 25, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Belantamab Mafodotin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 10, 2022

Head and Neck Cancer:Retrospective Analysis

Completed
  • Head and Neck Cancer
  • +2 more
  • multiparametric MRI
  • (no location specified)
Feb 23, 2022

Ulcerative Colitis Trial in San Francisco (Fecal Microbiota Transplantation (FMT), OpenBiome, pretreatment antibiotics)

Completed
  • Ulcerative Colitis
  • Fecal Microbiota Transplantation (FMT), OpenBiome
  • pretreatment antibiotics
  • San Francisco, California
    UCSF Division of Gastroenterology at Mount Zion
Apr 26, 2021

Atypical Antipsychotics inGeriatric Population: What is Role of

Recruiting
  • Neutropenia
    • Strasbourg, France
      Service de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
    Oct 27, 2023

    Temporomandibular Joint Disorders Trial in Cairo (Micro fragmented adipose tissue mixed with bone marrow stem cells, Bone Marrow

    Not yet recruiting
    • Temporomandibular Joint Disorders
    • Micro fragmented adipose tissue mixed with bone marrow stem cells
    • Bone Marrow stem cells aspirate
    • Cairo, Egypt
    • +1 more
    Apr 4, 2023

    Barrett Esophagus, Barretts Esophagus With Dysplasia, Barrett's Esophagus Without Dysplasia Trial in Jacksonville, Rochester

    Recruiting
    • Barrett Esophagus
    • +3 more
    • Cytosponge Procedure
    • Endoscopic Assessment
    • Jacksonville, Florida
    • +1 more
    Oct 3, 2023

    Development of B-cell Leukemias and Lymphomas in Children of

    Not yet recruiting
    • B Cell Leukemia
    • Lymphoma
    • SNP analysis of the DNA
    • (no location specified)
    Oct 26, 2021

    Lung Cancer, NSCLC, Stage III, NSCLC Stage IV Trial in Drammen (sotorasib)

    Recruiting
    • Lung Cancer
    • +6 more
    • Drammen, Viken, Norway
      Vestre Viken Health Trust
    May 30, 2022

    Lymphoma Trial in Worldwide (Bendamustine, Obinutuzumab, Polatuzumab vedotin (Liquid))

    Completed
    Has Results
    • Lymphoma
    • Birmingham, Alabama
    • +61 more
    Oct 18, 2022

    Tumors Trial in United States (Niraparib, Pembrolizumab, TSR-042 (Dostarlimab))

    Completed
    Has Results
    • Neoplasms
    • Whittier, Alaska
    • +15 more
    Aug 29, 2022

    Autologous Stem Cell Treatment for Chronic Lung Disease Study

    Completed
    Has Results
    • COPD
    • Interstitial Lung Disease
    • Cell therapy
    • Dallas, Texas
      Lung Institute Dallas
    Oct 11, 2018

    Resolving Inflammaging Allo HSCT Survivors in Personal Training

    Completed
    • Allogeneic HCT Survivors
    • 10 Weeks of Strength Trailing
    • Group Nutrition Discussion: week 1, week 5 and week 10
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Mar 31, 2022

    Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

    Recruiting
    • Endometrial Cancer
    • Uterine Cancer
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Sep 27, 2022

    EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

    Recruiting
    • EGFR NP_005219.2:p.S492R
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022